10.6084/m9.figshare.11364047.v1 Cynthia Shu Cynthia Shu Ariana Kaxon-Rupp Ariana Kaxon-Rupp Judd Collado Judd Collado Robert Damoiseaux Robert Damoiseaux Rachelle Crosbie Rachelle Crosbie MOESM4 of Development of a high-throughput screen to identify small molecule enhancers of sarcospan for the treatment of Duchenne muscular dystrophy Springer Nature 2019 Drug discovery Duchenne muscular dystrophy C2C12 Dystrophin Felodipine High-throughput screen Sarcolemma Sarcospan Small molecules 2019-12-13 07:39:47 Journal contribution https://springernature.figshare.com/articles/journal_contribution/MOESM4_of_Development_of_a_high-throughput_screen_to_identify_small_molecule_enhancers_of_sarcospan_for_the_treatment_of_Duchenne_muscular_dystrophy/11364047 Additional file 4: Figure S2. C2C12 myoblasts undergoing differentiation and fusion into myotubes. Confluent C2C12 myoblasts (day 0, D0) were switched from proliferation to differentiation media and imaged daily using phase contrast microscopy for 7 days (D1 to D7). Scale bar = 200 μm.